Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions

Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions

Item
http://www.wikidata.org/entity/Q26751258
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver diseaseInsulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells.Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes.Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.Increased liver AGEs induce hepatic injury mediated through an OST48 pathway.Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver.TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse.Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm.Ipragliflozin and sodium glucose transporter 2 inhibitors to reduce liver fat: will the prize we sought be won?Effect of Roux-en-Y gastric bypass on liver mitochondrial dynamics in a rat model of obesity.Zanthoxylum ailanthoides Suppresses Oleic Acid-Induced Lipid Accumulation through an Activation of LKB1/AMPK Pathway in HepG2 Cells.Inhibin βE (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples.The liver in focus.Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression.A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At-Risk Populations in Primary Care
P2860

Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions

Item
http://www.wikidata.org/entity/Q26751258
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Treatment of patients with typ ...... proaches and future directions
@ast
Treatment of patients with typ ...... proaches and future directions
@en
Treatment of patients with typ ...... proaches and future directions
@nl
type
label
Treatment of patients with typ ...... proaches and future directions
@ast
Treatment of patients with typ ...... proaches and future directions
@en
Treatment of patients with typ ...... proaches and future directions
@nl
prefLabel
Treatment of patients with typ ...... proaches and future directions
@ast
Treatment of patients with typ ...... proaches and future directions
@en
Treatment of patients with typ ...... proaches and future directions
@nl
P1433
P1476
P2093
P275
P2860
P2888
P304
P31
P3181
P356
P407
P433
P478
P5008
P577
P6179
P698
P921
P932
P3181
P356
P1433
P1476
Treatment of patients with typ ...... proaches and future directions
@en
P2093
P275
P2860
P2888
P304
P31
P3181
P356
P407
P433
P478
P5008
P577
P6179
P698
P921
P932